Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT

RCT (n=503) did not find a benefit of the vaccine; odds of clearance at week 16 and remaining clear at week 48 were 46% higher with vaccine, but difference was not statistically significant. Imiquimod and podophyllotoxin creams had similar efficacy for wart clearance.

Source:

National Institute for Health Research